Medicure Inc. (CVE:MPH – Get Free Report) passed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of C$0.92 and traded as low as C$0.88. Medicure shares last traded at C$0.88, with a volume of 2,700 shares changing hands.
Medicure Trading Down 1.1 %
The company has a current ratio of 1.87, a quick ratio of 1.29 and a debt-to-equity ratio of 2.06. The stock has a 50-day simple moving average of C$0.92 and a 200 day simple moving average of C$0.99. The company has a market cap of C$9.08 million, a price-to-earnings ratio of -3.48 and a beta of 0.90.
Medicure Company Profile
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Recommended Stories
- Five stocks we like better than Medicure
- What Are Growth Stocks and Investing in Them
- 3 Legacy Tech Companies Reemerging as AI Leaders
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
